Overview

Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study was to explore the effects of pain on the one hand and the effects of treatment of pain with gabapentin (900, 1200, 1800 or 2400 mg) on the other hand on actual driving performance and several laboratory tests in patients with neuropathic pain. It was hypothesized that gabapentin might influence performance after acute but not after subchronic administration.
Phase:
Phase 4
Details
Lead Sponsor:
UMC Utrecht
Collaborator:
Utrecht University
Treatments:
Gabapentin
gamma-Aminobutyric Acid